TE_34324

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MER21B, MER21A
TE superfamily ERV3
TE class LTR
Gene ZNF471
Class Chimeric
Coding Non-coding
Tumor-specific score 0.04
Counts of samples TCGA_tumor:103; TCGA_normal:2; GTEx:2643
TSS chr19(+):56509617



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_34324.1 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510900,56511517,56511604,56516275,56516401,56518482,56518502
teRNA_34324.2 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510973,56511517,56511604,56516275,56516401,56518482,56518577,56524745,56524765
teRNA_34324.3 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510973,56511517,56511604,56516275,56516401,56518482,56518577,56524324,56524344
teRNA_34324.4 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510973,56511517,56511604,56516275,56516401,56518482,56518502
teRNA_34324.5 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510923,56511517,56511604,56516275,56516401,56518482,56518577,56524745,56524765
teRNA_34324.6 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510923,56511517,56511604,56516275,56516401,56518482,56518577,56524324,56524344
teRNA_34324.7 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56510923,56511517,56511604,56516275,56516401,56518482,56518502
teRNA_34324.8 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56511604,56516275,56516401,56518482,56518577,56524745,56524765
teRNA_34324.9 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56511604,56516275,56516401,56518482,56518577,56524324,56524344
teRNA_34324.10 ZNF471 Chimeric Non-coding Non-coding chr19(+):56509618,56509637,56509673,56511604,56516275,56516401,56518482,56518502


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).